Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

CIBC donates $1M to support the future of patient-centered care at the MUHC

Published

on

MONTREAL, June 14, 2022 (GLOBE NEWSWIRE) — Navigating the health care system can be overwhelming. An innovative app improving the patient experience at the MUHC is expanding thanks to a $1 million gift from CIBC to the MUHC Foundation. Created by the Opal Health Informatics Group – a passionate group of patients, clinicians, researchers, and students at the Research Institute of the McGill University Health Centre (RI-MUHC), the Opal app provides patients access to their hospital appointments, laboratory test results, some clinical notes written by their doctors, and educational material about their illness and treatments. The result is a more empowered experience for patients—with their health information at their fingertips, they feel in control of their journey.

“It is deeply satisfying for our healthcare professionals at the McGill University Health Centre to co-create projects with patients that improve the patient experience. Opal is a product of this vital collaboration and I look forward to seeing it evolve.”

— Dr. Pierre Gfeller, President and Executive Director, MUHC

Opal was created when the late Laurie Hendren, a Professor of Computer Science at McGill University and breast cancer patient, teamed up with her radiation oncologist, Dr. Tarek Hijal, and with medical physicist and cancer researcher Dr. John Kildea to empower patients during their care and improve their experience. Currently, Opal is used by cancer patients at the MUHC, as well as by patients with inflammatory bowel disease and HIV, and the parents of children with kidney disease.

“Laurie was the driving force behind the app. She understood how difficult it can be to keep track of dozens of appointments and the need for patients to access their own personal health information while dealing with the stress of a cancer diagnosis.”

— Dr. Tarek Hijal, Chief of Radiation Oncology at the MUHC, Clinical Lead of the Quebec SmartCare Consortium and Opal Co-Creator

With CIBC’s support, Opal will be expanded to enhance patient care and research as the centrepiece of an innovative new project known as the Quebec SmartCare Consortium (quebecsmartcare.com). As the project progresses, participating physicians will be able to monitor their patients between appointments using wearable devices that track vital signs. Remote monitoring will provide physicians a steady stream of data to help them better understand each patient’s condition. It will also provide patients the reassurance that anomalies in their health will be noticed by their health care team and addressed quickly.

“The incredible team at McGill University Health Centre continuously helps improve the functioning of our healthcare systems through the implementation of innovative tools like Opal,” said Rosa Trunzo, Vice President and Region Head, Quebec at CIBC. “On behalf of CIBC, we’re proud to support their ambition to provide exceptional and integrated patient-centric care for those living with cancer, as we collectively work towards a future where no one has to fear a cancer diagnosis.”

Opal is also a powerful tool for research. Patients will be able to share their anonymized data with scientists to enable studies that will ultimately improve patient care.

“Opal not only helps patients feel in control of their health care journey, it creates an immense opportunity to work with patients to collect real-world data to improve our understanding of treatments, monitor and minimize side effects, identify gaps in care, develop new treatment options and much more.”

— Dr. John Kildea, Cancer Researcher at the RI-MUHC, Principal Investigator of the Quebec SmartCare Consortium and Opal Co-Creator

As Opal’s capabilities grow, ​​thanks to the investments of the public and private partners who are participating in the Quebec SmartCare Consortium as well as funding from the Ministry of Economy and Innovation, its creators are expanding the reach of the app within the MUHC and, for the first time, to another Quebec hospital. In the same way that technology has changed so many aspects of our lives, Opal will change how we navigate the healthcare system.

“The MUHC Foundation is grateful to CIBC for its generous gift to support Opal. Receiving a life-changing diagnosis is always difficult, and anything that can help alleviate the stress of treatment makes a huge difference for patients. With CIBC’s help, Opal will become a key resource for patients and physicians across the MUHC”

— Suzanne Legge Orr, Dream Big Campaign Co-Chair, MUHC Foundation

To enable Opal to reach this milestone expansion, the MUHC Foundation is raising another $500,000. Please help us reach this goal: https://muhcf.akaraisin.com/ui/opal

About the McGill University Health Centre Foundation
The McGill University Health Centre (MUHC) Foundation raises funds to support excellence in patient care, research and teaching at the McGill University Health Centre, one of the top university hospitals in Canada. Our Dream Big Campaign to change the course of lives and medicine is raising millions of dollars to solve humanity’s deadliest puzzles: infectious diseases; end cancer as a life-threatening illness; fix broken hearts through innovative cardiac care; detect the silent killers—ovarian and endometrial cancers—early; create the best skilled health care teams in Canada; and much more. We are rallying our entire community to solve the world’s most complex health care challenges. www.muhcfoundation.com

About the RI-MUHC
The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and healthcare research centre. The institute, which is affiliated with the Faculty of Medicine of McGill University, is the research arm of the McGill University Health Centre (MUHC) – an academic health centre located in Montreal, Canada, that has a mandate to focus on complex care within its community. The RI-MUHC supports over 450 researchers and around 1,200 research trainees devoted to a broad spectrum of fundamental, clinical and health outcomes research at the Glen and the Montreal General Hospital sites of the MUHC. Its research facilities offer a dynamic multidisciplinary environment that fosters collaboration and leverages discovery aimed at improving the health of individual patients across their lifespan. The RI-MUHC is supported in part by the Fonds de recherche du Québec – Santé (FRQS). www.rimuhc.ca

About CIBC
CIBC is a leading North American financial institution with 11 million personal banking, business, public sector and institutional clients. Through corporate donations, community partnerships and the genuinely caring culture of Team CIBC, we are committed to helping people and our communities make their ambitions a reality. Learn more about our community impact. Ongoing news releases and more information about CIBC can be found at https://www.cibc.com/en/about-cibc/media-centre.html.

About the Quebec SmartCare Consortium
The Quebec SmartCare Consortium is an innovative three-year project led by the Opal Health Informatics Group at the RI-MUHC that is bringing together a group of key public and private healthcare organizations in Quebec that are working on digital health solutions. It aims to demonstrate the power of SmartCare, which it defines as the use of patient-centered data and mobile health technologies to drive remote monitoring and artificial intelligence research in healthcare. The consortium is made possible thanks to generous funding from the Health Collaborations Accelerator Fund of the Quebec Ministry of Economy and Innovation and private partners Roche, Novartis, the McGill University Health Centre Foundation and the Cedars Cancer Foundation. Quebec companies VitalTracer, iMD Research, My Intelligent Machines and Imagia are contributing their technologies and expertise, in collaboration with MUHC patients and partners at McGill University, CHU Ste-Justine, Université de Montreal, Phyla Inc. and Mila. www.quebecsmartcare.com  

Contacts:

Tarah Schwartz
Director, Communications and Marketing
McGill University Health Centre Foundation
[email protected]

Kelly Albert
Senior Communications Officer
McGill University Health Centre Foundation
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d89808e1-3344-4de9-a557-70039b791060

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

XtalPi Unveils XtalGazer: A Comprehensive AI-Driven Polymorph Selection Platform

Published

on

xtalpi-unveils-xtalgazer:-a-comprehensive-ai-driven-polymorph-selection-platform

CAMBRIDGE, Mass., March 28, 2024 /PRNewswire/ — XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approaches.

XtalGazer provides a total solution for delivering high-quality polymorph screening and selection methods to expedite drug development and mitigate risks. It represents a paradigm shift in solid-state research, moving from the traditional trial-and-error approach to a data-driven, design-led methodology. The platform provides an expansive suite of foundational tools to accelerate polymorph discovery, characterization, and selection process, empowering pharmaceutical companies to conduct thorough research with less active pharmaceutical ingredient (API) in shorter development cycles.
A key component of XtalGazer is XtalCSP, a crystal structure prediction platform to perform global searches of crystal structures for target molecules and the other optional components in the corresponding searching space, offering a deep insight into possible stable forms. Furthermore, crystallization strategy recommendations will provide AI-backed experimental design to help avoid human bias. XtalGazer also utilizes MicroED to rapidly elucidate crystal structures from powder samples, reducing the need for growing single crystals.
XtalPi’s launch of XtalGazer marks another significant step in the company’s ongoing exploration of solid-state research. From crystal structure prediction platforms being one of the first products to launch at XtalPi, to today’s comprehensive polymorph selection platform, XtalPi will keep fulfilling its promise to solving challenging problems in this space. XtalPi will continue to deliver faster, more accurate, and more comprehensive approaches to building an ecosystem for the R&D process in solid-state, pre-formulation and crystallization.
For more information about XtalPi, please visit www.xtalpi.com.
About XtalPi:
XtalPi is an innovative technology company powered by artificial intelligence (AI) and robotics. Founded in 2015 on the MIT campus, XtalPi is dedicated to driving intelligent and digital transformation in the life science and new materials industries. With tightly interwoven quantum physics, AI, cloud computing, and large-scale clusters of robotic workstations, XtalPi offers a range of technology solutions, services, and products to accelerate and empower innovation for biopharmaceutical and new materials companies worldwide.
Media Contact: Vivienne [email protected]
Logo – https://mma.prnewswire.com/media/632519/XtalPi_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/xtalpi-unveils-xtalgazer-a-comprehensive-ai-driven-polymorph-selection-platform-302102794.html

Continue Reading

Artificial Intelligence

ICIS and Base Oil News Announce Partnership to Enhance Market Insights

Published

on

icis-and-base-oil-news-announce-partnership-to-enhance-market-insights

LONDON, March 28, 2024 /PRNewswire/ — ICIS, a global source of commodity intelligence, is pleased to announce a strategic partnership with Base Oil News, a premier news outlet founded by industry expert Iain Pocock that provides in-depth coverage of the base oils and lubricants market. This collaboration marks a significant milestone in the dissemination and exchange of critical market data and insights.

With more than two decades of journalism experience at Bloomberg, Reuters, and Argus Media, Iain Pocock brings unparalleled expertise to this partnership. His deep understanding of illiquid energy markets makes him a credible and influential figure in the industry. Since November 2023, Iain has been working closely with ICIS to share and exchange valuable data and insights, enhancing the services both platforms offer to the base oils and lubricants market.
Through the collaboration, Iain integrates ICIS’ extensive content and data resources in Base Oil News market coverage. In return, he contributes market insights to ICIS News, including expert and exclusive analysis of supply and demand dynamics, price margins, and other critical market drivers. This exchange ensures that subscribers of both ICIS and Base Oil News have access to the most comprehensive, timely, and accurate market information, empowering them to make informed decisions.
“It’s a very exciting partnership – where we leverage each other’s strengths and provide actionable insights to our customers,” said Iain Pocock, Founder of Base Oil News. “The market is the winner.”
“As ICIS is already the world’s most trusted pricing benchmark for base oils, this collaboration with Iain Pocock and Base Oil News provides an even stronger and deeper service to our customers,” said Stephen Burns, Editorial Director at ICIS. “Iain’s expertise and extensive industry connections are invaluable, and we have established a fruitful partnership that benefits the market at large.”
For the latest insights from Iain Pocock on ICIS News, visit ICIS News.  
About ICIS
ICIS – Independent Commodity Intelligence Services – helps businesses through seamlessly delivering data and analytics, across the chemical, fertilizer and energy markets. A trusted source and benchmark for price information and insight across key commodities markets worldwide. Our independent, transparent market intelligence informs thousands of quality decisions every day, taking the pressure out of negotiations and giving customers space for more innovative thinking, through published datasets including price assessments, price forecasts, supply and demand fundamentals and more.
Over 150 years of shaping the world by connecting markets to optimise the world’s valuable resources. With a global team of more than 600 experts, ICIS has employees based in London, New York, Houston, Karlsruhe, Milan, Mumbai, Singapore, Guangzhou, Beijing, Shanghai, Dubai, Sao Paulo, Seoul, Tokyo and Perth.
ICIS is part of RELX, a FTSE15 company with a market cap of £64bn and an employee base of over 30,000 experts across 40 countries.
About RELX
RELX is a global provider of information and analytics for professional and business customers across industries. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs approximately 30,000 people of whom almost half are in North America. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. The shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX and RENX. Total market capitalisation is approximately £64bn | €75bn | $81bn.
Logo: https://mma.prnewswire.com/media/619935/4277787/ICIS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/icis-and-base-oil-news-announce-partnership-to-enhance-market-insights-302102782.html

Continue Reading

Artificial Intelligence

Trianz Welcomes Israel Abraham as Vice President of Services for Extrica.ai – The Data to AI Platform

Published

on

trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extrica.ai-–-the-data-to-ai-platform

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ — Digital transformation technology & services company Trianz is pleased to announce the appointment of Israel Abraham as Vice President of Extrica Platform Services.

Trianz has embarked on a transformative journey, redefining its value proposition with an ‘IP Led’ model, with a commitment to deliver the fastest time to value, lowest human dependence, and highest ROI. Central to this approach are our hyper-automated platforms, Concierto.Cloud, Extrica.AI, and Pulse, driving industry-leading transformations in cloud, data and analytics, AI, and the digital workplace.
Israel Abraham is a very well-known pioneer and industry leader in AI, data management, and analytics systems, with over three decades of experience. He joins as the services leader for Extrica- the Trianz Data to AI platform, which productizes data, provides data a face and purpose, and accelerates time to insights and AI by 50% or more. In the role of Extrica Services leader, Israel will lead the shaping, visioning, and delivery of Extrica.ai based enterprise wide datamesh, BI, and AI solutions for customers worldwide.
“We are thrilled to welcome Israel Abraham to the Trianz family,” said Sri Manchala, CEO of Trianz and author of Crossing the Digital Faultline. “He is a leader in modernization as well as conceptualization of data platforms anew. Israel’s prior background in the industry with financial services and insurance giants underscores our commitment to securing top-tier talent that brings real-world experiences and needs to our technology platforms. As we continue to broaden our footprint in the digital transformation space, Israel’s visionary leadership and practical experience will serve as the cornerstone in accelerating insights and AI to deliver transformative value to our clients.”
Having played pivotal roles in highly reputed and large organizations such as Liberty Mutual Insurance, MassMutual, Safeco, and CNA Insurance, Israel has garnered recognition as a seasoned leader in big data and AI cloud implementations. His accolades include the prestigious 2014 Ventana Research IT Innovation Award, the 2009 Informatica MDM Innovation Award, and three filed Data Engineering patents in the last four years.
“Trianz has been at the forefront of digital innovation, and Extrica.ai is a paradigm shifting data to AI platform that completely changes how analytics and AI are delivered- much faster, taking business ahead of change. I am excited to scale the adoption of the Extrica platform, which has attracted attention from giants across the industry and hyperscalers,” said Israel Abraham. “I look forward to engaging with customers, bringing my own experiences, and collaborating with the talented team at Trianz to further enhance the capabilities of the Extrica Platform Services to transform data & AI strategies, execution, and outcomes for customers.”
About Trianz
Trianz is a leading-edge technology platforms and services company that accelerates digital transformations at Fortune 100 and emerging companies worldwide in data & analytics, digital experiences, cloud infrastructure, and security. Our ‘IP Led Transformations’ approach, informed by insights from a recent global study spanning 20+ industries and 5000+ companies, addresses challenges posed by the rapid pace of AI-driven transformation, digital talent scarcity, and economic uncertainty. Our IP and platforms, including Concierto, Extrica, and Pulse, revolutionize cloud adoption, data analytics, and AI insights, empowering organizations to navigate the complexities of digital transformation seamlessly.
Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz is a Premier Partner of AWS, consistently rated #1 by clients for value delivery over the past five years. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit www.trianz.com.
Watch Trianz CEO Sri Manchala’s insightful interview with Bloomberg on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube and delve deeper into his book Crossing the Digital Faultline at Crossing the Digital Faultline | Trianz.
Trianz Media [email protected] +1-408-387-5800
Logo: https://mma.prnewswire.com/media/626944/1199800/Trianz_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/trianz-welcomes-israel-abraham-as-vice-president-of-services-for-extricaai–the-data-to-ai-platform-302102589.html

Continue Reading
Advertisement

Latest News

Trending